Ajanta Pharma reports strong Q1 FY27 results, but management remains cautious about sustainability, guiding for normalization in the US and acknowledging geopolitical headwinds in Asia.
Karnataka Bank provided an updated profile for its newly appointed Additional Director, Mr. Parthasarathi Periaswamy, who joined the board on July 29, 2026.
Rainbow Children’s Medicare Limited reports Q1 FY27 revenue of INR 4,700 Mn (+33% YoY) and EBITDA of INR 1,346.5 Mn (+30% YoY). Strategic focus on Hub and Spoke model expansion and JCI accreditation.
Jagsonpal reported a strong Q1FY27 with 9% revenue growth and 22% PAT growth, outperforming industry rates. The focus is on higher-margin specialty segments and integrating the Equitas acquisition to enter the hospital channel.
Global Health reported Q1 FY2027 revenue of ₹1,326.2 Crore, up 26.2% YoY. The company added 72 beds during the quarter and plans a 650-bed Guwahati expansion.
Shristi Infrastructure Development Corporation Ltd incorporated a new wholly owned subsidiary, Shristi Realty Holdings Limited, to acquire new business ventures.
Honda India Power Products Ltd. appointed Mr. Sameer Jain as CFO, effective October 1, 2026. Simultaneously, Mr. Vinay Mittal will cease his role as CFO and Executive Director.
Worldwide Aluminium Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026. This is a routine regulatory compliance filing.
Shalby Limited approved availing working capital facilities totaling ₹129.70 crore from Kotak Mahindra Bank Limited. This includes funding for both the company and its US subsidiary.
Tree House Education & Accessories Ltd. has scheduled a board meeting for August 7, 2026, to approve the standalone and consolidated financial results for the June quarter.
Embassy Office Parks REIT is acquiring a 0.6-acre land parcel contiguous to its Embassy Manyata Business Park. This strategic land acquisition is valued at ₹11.7 Crore.
Havells India is conducting a postal ballot to seek shareholder approval for the appointment of Shri Ashish Dhawan and Ms Shanti Ekambaram as independent directors.
Gayatri BioOrganics Ltd has scheduled a board meeting on 04.08.2026 to consider and approve the un-audited financial results for the quarter ended 30.06.2026.
This filing provides the quarterly shareholding pattern of IFB Agro Industries Ltd for the period ending March 31, 2026. It details the distribution of promoter and public shareholding.
Fredun Pharmaceuticals Ltd has scheduled a board meeting on August 5, 2026, to consider and approve its unaudited financial results for the quarter ended June 30, 2026.